← Back to Clinical Trials
Recruiting NCT07693699

NCT07693699 Optimizing Sustainable Cuff Access and Training Pathways for Self-Measured Blood Pressure Monitoring in Primary Care

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07693699
Status Recruiting
Phase
Sponsor Wake Forest University Health Sciences
Condition Hypertension
Study Type INTERVENTIONAL
Enrollment 150 participants
Start Date 2026-07-30
Primary Completion 2026-10-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
In-Clinic Cuff Delivery - Enhanced Return ConversationIn-Clinic Cuff Delivery - Written InstructionsMail Order Cuff Delivery - Enhanced Return Conversation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 150 participants in total. It began in 2026-07-30 with a primary completion date of 2026-10-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to identify what cuff delivery and BP log return modality most effectively achieve successful delivery of a self-measured blood pressure (SMBP) intervention in routine care, among adult primary care patients with uncontrolled hypertension?

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older. * Diagnosed hypertension documented prior to the index clinic visit. * Scheduled for and attends an in-person visit with a participating clinician at a study clinic. * Elevated BP (blood pressure) documented in Epic during rooming or the clinic visit before study enrollment, defined as systolic BP \>=140 mmHg or diastolic BP \>=90 mmHg. Exclusion Criteria: * Visit is canceled, rescheduled, or the patient does not attend the visit. * Patient already has a usable home BP cuff provide through insurance within the past 5 years. * Patient declines assistance obtaining a BP cuff. * Patient declines submitting cuff order to insurance. * Patient unable to participate for operational reasons.

Contact & Investigator

Central Contact

Rasha Khatib, PhD

✉ Rasha.Alkhatib@aah.org

📞 7086843691

Principal Investigator

Rasha Khatib, PhD

PRINCIPAL INVESTIGATOR

Advocate Health

Frequently Asked Questions

Who can join the NCT07693699 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07693699 currently recruiting?

Yes, NCT07693699 is actively recruiting participants. Contact the research team at Rasha.Alkhatib@aah.org for enrollment information.

Where is the NCT07693699 trial being conducted?

This trial is being conducted at Chicago, United States, Chicago, United States, Chicago, United States, Merrionette Park, United States and 2 additional locations.

Who is sponsoring the NCT07693699 clinical trial?

NCT07693699 is sponsored by Wake Forest University Health Sciences. The principal investigator is Rasha Khatib, PhD at Advocate Health. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology